BAXJECT III reconstitution system

Shire plc: U.S. FDA approved the BAXJECT III reconstitution system for ADYNOVATE

New system reduces number of steps in the treatment process for hemophilia A patients on ADYNOVATE [Antihemophilic Factor, (Recombinant), PEGylated]…

8 years ago